Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
3.555
-0.205 (-5.45%)
At close: Jan 21, 2025, 4:00 PM
3.709
+0.153 (4.32%)
After-hours: Jan 21, 2025, 4:13 PM EST
Trevi Therapeutics Employees
Trevi Therapeutics had 25 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
25
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,772,680
Market Cap
273.26M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
TRVI News
- 13 days ago - Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference - PRNewsWire
- 5 weeks ago - Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering - PRNewsWire
- 5 weeks ago - Why Is Cough-Focused Trevi Therapeutics Stock Skyrocketing On Thursday? - Benzinga
- 5 weeks ago - Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough - PRNewsWire
- 7 weeks ago - Trevi Therapeutics Announces Positive Topline Results from Human Abuse Potential Study of Oral Nalbuphine - PRNewsWire
- 2 months ago - Trevi Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 2 months ago - Trevi Therapeutics, Inc. (TRVI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates - PRNewsWire